Introduction: Nigeria is among the top ten countries with a high burden of Tuberculosis (TB) worldwide. Drug-resistant TB is a global health burden, but disproportionately higher among TB patients in resource-constrained countries like Nigeria. We described the pattern of resistance to first-line anti-TB drugs among patients tested at the National Tuberculosis and Leprosy Control Program (NTBLCP) reference laboratory in Abuja, Nigeria.
No takes yet. Share an insight, caveat, or question.
Chukwuemeka Anthonia (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: